ATR and cancer: However, activation of CHK1 was shown to circumvent replication catastrophe associated with ATR inhibition (Buisson et al., 2015) and co-inhibition of CHK1 produced synthetic lethality in cancer cells through CDK-dependent origin firing (Sanjiv et al., 2016).